mRNA COVID-2019 vaccine (eTheRNA Immunotherapies)

N/A

Report date: 2024/05/11 18:35:39

Base Information

Drug NamemRNA COVID-2019 vaccine (eTheRNA Immunotherapies)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompanieseTheRNA Immunotherapies NV

China Registration ClassN/A

Develop Information

Active CompanieseTheRNA Immunotherapies NV

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A